Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
Authors
Keywords
COVID-19, Death, Mechanical ventilation, Metformin, Propensity score, Type 2 diabetes
Journal
DIABETES & METABOLISM
Volume -, Issue -, Pages 101216
Publisher
Elsevier BV
Online
2020-12-11
DOI
10.1016/j.diabet.2020.101216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Context-Dependent Pharmacological Effects of Metformin on the Immune System
- (2020) Fabrizio Marcucci et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19
- (2020) Javier A. Menendez Aging-US
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Benefits of Metformin in Attenuating the Hallmarks of Aging
- (2020) Ameya S. Kulkarni et al. Cell Metabolism
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations
- (2020) Franz H. Messerli et al. CIRCULATION
- Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports
- (2020) André J. Scheen et al. DIABETES & METABOLISM
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Metformin and COVID-19: From cellular mechanisms to reduced mortality
- (2020) A.J. Scheen DIABETES & METABOLISM
- Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
- (2020) Awadhesh Kumar Singh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Management of diabetes in patients with COVID-19
- (2020) Jean-Daniel Lalau et al. Lancet Diabetes & Endocrinology
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report
- (2020) Yongchao Gao et al. CTS-Clinical and Translational Science
- Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study
- (2020) Bertrand Cariou et al. DIABETES & METABOLISM
- Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
- (2020) Luis M. Pérez-Belmonte et al. BMC Medicine
- Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
- (2020) Jun Young Do et al. DIABETES & METABOLISM
- Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis
- (2019) Vahid Kheirollahi et al. Nature Communications
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
- (2019) Marc Foretz et al. Nature Reviews Endocrinology
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- Is metformin poised for a second career as an antimicrobial?
- (2018) Faiza Malik et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The Therapeutic Potential of Metformin in Neurodegenerative Diseases
- (2018) Carola Rotermund et al. Frontiers in Endocrinology
- Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
- (2016) Nisa M. Maruthur et al. ANNALS OF INTERNAL MEDICINE
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusNovelty and Significance
- (2016) Amy R. Cameron et al. CIRCULATION RESEARCH
- Metformin Use and Mortality Among Patients With Diabetes and AtherothrombosisMetformin Use With Diabetes and Atherothrombosis
- (2010) Ronan Roussel ARCHIVES OF INTERNAL MEDICINE
- The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies
- (2010) Peter C. Austin STATISTICS IN MEDICINE
- The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies
- (2009) Peter C. Austin MEDICAL DECISION MAKING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More